Skip to content
2000
Volume 29, Issue 17
  • ISSN: 1385-2728
  • E-ISSN: 1875-5348

Abstract

Gossypol has been shown to be a promising natural product for the anticancer drug development for treating leukemia, lymphoma, colon carcinoma, breast cancer, and other malignant disease. It is known that the conversion of aldehyde groups of gossypol into iminofragments by the treatment of various amines can reduce the toxicity of the derivative and simultaneously increase their pharmacological efficacy. This article describes the preparation and screening of antiproliferative properties of a conjugate of gossypol with antitumor antibiotic doxorubicin. It has been shown that the reaction of the amino group of doxorubicin with the aldehyde groups of gossypol gives the condensation product in which two pharmacophores are linked enamine–enamine moieties. However, this conjugation decreased the antiproliferative activity of paternal doxorubicin and gossypol against chronic myeloid leukemia cells K562 and led to dramatic loss of potency against MDR-subline K-562/4 with expression of Р- (Р-gp).

Loading

Article metrics loading...

/content/journals/coc/10.2174/0113852728358616241226064825
2025-01-28
2025-08-13
Loading full text...

Full text loading...

References

  1. Keshmiri-NeghabH. GoliaeiB. Therapeutic potential of gossypol: An overview.Pharm. Biol.201452112412810.3109/13880209.2013.832776 24073600
    [Google Scholar]
  2. LuY. LiJ. DongC.E. HuangJ. ZhouH.B. WangW. Recent advances in gossypol derivatives and analogs: A chemistry and biology view.Future Med. Chem.20179111243127510.4155/fmc‑2017‑0046 28722469
    [Google Scholar]
  3. LiuY. WangL. ZhaoL. ZhangY. Structure, properties of gossypol and its derivatives—from physiological activities to drug discovery and drug design.Nat. Prod. Rep.20223961282130410.1039/D1NP00080B 35587693
    [Google Scholar]
  4. LiL. LiZ. WangK. LiuY. LiY. WangQ. Synthesis and antiviral, insecticidal, and fungicidal activities of gossypol derivatives containing alkylimine, oxime or hydrazine moiety.Bioorg. Med. Chem.201624347448310.1016/j.bmc.2015.08.015 26337022
    [Google Scholar]
  5. TienV.D. Van VuV. KoeckritzA. NhungT.T. ThaoD.T. VuT.K. Novel (-)-gossypol derived hydrazones: Synthesis and biological evaluation.AIP Conf. Proc.2017187802001010.1063/1.5000178
    [Google Scholar]
  6. YangJ. ChenG. LiL.L. PanW. ZhangF. YangJ. WuS. TienP. Synthesis and anti-H5N1 activity of chiral gossypol derivatives and its analogs implicated by a viral entry blocking mechanism.Bioorg. Med. Chem. Lett.20132392619262310.1016/j.bmcl.2013.02.101 23538114
    [Google Scholar]
  7. PaunovicD. RajkovicJ. NovakovicR. Grujic-MilanovicJ. MekkyR.H. PopaD. CalinaD. Sharifi-RadJ. The potential roles of gossypol as anticancer agent: Advances and future directions.Chin. Med.202318116310.1186/s13020‑023‑00869‑8 38098026
    [Google Scholar]
  8. PalD. SahuP. SethiG. WallaceC.E. BishayeeA. Gossypol and its natural derivatives: Multitargeted phytochemicals as potential drug candidates for oncologic diseases.Pharmaceutics20221412262410.3390/pharmaceutics14122624 36559116
    [Google Scholar]
  9. XiongJ. LiJ. YangQ. WangJ. SuT. ZhouS. Gossypol has anti-cancer effects by dual-targeting MDM2 and VEGF in human breast cancer.Breast Cancer Res.20171912710.1186/s13058‑017‑0818‑5 28274247
    [Google Scholar]
  10. StepanovA.V. YarovenkoV.N. NasyrovaD.I. DezhenkovaL.G. AkchurinI.O. KrayushkinM.M. IlyushenkovaV.V. ShchekotikhinA.E. TretyakovE.V. A spin-labeled derivative of gossypol.Molecules20242920496610.3390/molecules29204966 39459334
    [Google Scholar]
  11. StepanovA.V. YarovenkoV.N. KrayushkinM.M. Reaction of gossypol with thiohydrazides of oxamic acids.Russ. Chem. Bull.202473243744110.1007/s11172‑024‑4150‑9
    [Google Scholar]
  12. MikhajlovichK.M. NikolaevichY.V. SergeevichZ.E. LeonidovichG.A. AkhatovnaZ.N. VladimirovnaZ.V. AleksandrovnaT.E. IgorevnaT.D. N-Substituted Derivatives of Oxamic Acid Thiohydrazides, Synthesis Method and Use Thereof.Russian Patent RU2400471C12009
  13. GinzburgA.L. ZigangirovaN.A. ZorinaV.V. TokarskayaE.A. TartakovskayaD.I. KrayushkinM.M. YarovenkoVN. ZayakinE.S. Pathogenic bacteria inhibiting biologically active substances.Russian Patent RU2402531C22008
  14. GinzburgA.L. ZigangirovaN.A. ZayakinE.S. KrayushkinM.M. YarovenkoV.N. Pathogenic bacteria-inhibiting biologically active substances and method of inhibiting pathogenic bacteria type iii secretion.Russian Patent RU2447066C22010
  15. LindersA.N. DiasI.B. López FernándezT. TocchettiC.G. BomerN. Van der MeerP. A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging.NPJ Aging2024101910.1038/s41514‑024‑00135‑7 38263284
    [Google Scholar]
  16. RennerO. MayerM. LeischnerC. BurkardM. BergerA. LauerU.M. VenturelliS. BischoffS.C. Systematic review of gossypol/AT-101 in cancer clinical trials.Pharmaceuticals202215214410.3390/ph15020144 35215257
    [Google Scholar]
  17. PeterS. AlvenS. MasekoR.B. AderibigbeB.A. Doxorubicin-based hybrid compounds as potential anticancer agents: A review.Molecules20222714447810.3390/molecules27144478 35889350
    [Google Scholar]
  18. MicallefI. BaronB. Doxorubicin: An overview of the anti-cancer and chemoresistance mechanisms.Ann. Clin. Toxicol2020321031
    [Google Scholar]
  19. KciukM. GielecińskaA. MujwarS. KołatD. Kałuzińska-KołatŻ. CelikI. KontekR. Doxorubicin-an agent with multiple mechanisms of anticancer activity.Cells202312465910.3390/cells12040659 36831326
    [Google Scholar]
  20. PrzybylskiP. HuczynskiA. PytaK. BrzezinskiB. BartlF. Biological properties of Schiff bases and azo derivatives of phenols.Curr. Org. Chem.200913212414810.2174/138527209787193774
    [Google Scholar]
  21. NacaroğluballiJ. KirpikH. KöseM. A Gossypol-hydrazone compound and its sensing properties towards metal ions and nitro-phenolic compounds.J. Mol. Struct.2021123613031010.1016/j.molstruc.2021.130310
    [Google Scholar]
  22. PrzybylskiP. MałuszyńskaM. BrzezinskiB. Spectroscopic and semiempirical studies of new Schiff base of gossypol with allylamine in solution.J. Mol. Struct.20057501-315215710.1016/j.molstruc.2005.04.027
    [Google Scholar]
  23. TikhomirovA.S. TsvetkovV.B. VolodinaY.L. LitvinovaV.A. AndreevaD.V. DezhenkovaL.G. KaluzhnyD.N. TreshalinI.D. ShtilA.A. ShchekotikhinA.E. Heterocyclic ring expansion yields anthraquinone derivatives potent against multidrug resistant tumor cells.Bioorg. Chem.202212710592510.1016/j.bioorg.2022.105925 35728293
    [Google Scholar]
  24. Martins-TeixeiraM.B. CarvalhoI. Antitumour Anthracyclines: Progress and Perspectives.ChemMedChem2020151193394810.1002/cmdc.202000131 32314528
    [Google Scholar]
  25. TikhomirovA.S. LitvinovaV.A. AndreevaD.V. TsvetkovV.B. DezhenkovaL.G. VolodinaY.L. KaluzhnyD.N. TreshalinI.D. ScholsD. RamonovaA.A. MoisenovichM.M. ShtilA.A. ShchekotikhinA.E. Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties.Eur. J. Med. Chem.202019911229410.1016/j.ejmech.2020.112294 32428792
    [Google Scholar]
  26. LitvinovaV.A. TsvetkovV.B. VolodinaY.L. DezhenkovaL.G. MarkovaA.A. NguyenM.T. TikhomirovA.S. ShchekotikhinA.E. Naphthoindole-2-carboxamides as a lipophilic chemotype of hetarene-anthraquinones potent against P-gp resistant tumor cells.Eur. J. Med. Chem.202528111701310.1016/j.ejmech.2024.117013 39500064
    [Google Scholar]
/content/journals/coc/10.2174/0113852728358616241226064825
Loading
/content/journals/coc/10.2174/0113852728358616241226064825
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.


  • Article Type:
    Research Article
Keyword(s): anticancer drug; antiproliferative activity; doxorubicin; enamines; Gossypol; imines
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test